Cart
This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Deleting

No Items In Cart
We apologize your item could not be found. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West’s Graham Reynolds will present “An Integrated Approach to Biologic Drug Delivery Systems: Meeting the needs of the patient, and optimizing drug product performance,” at the Drug Delivery Partnerships meeting in Las Vegas, on January 25, 2012.
Graham will speak at a session entitled “Maximize the potential of your drug delivery system through drug device combination products,” chaired by Phil Green, Senior Director Drug Delivery Devices at Merck.
The presentation will focus on the importance of considering four key elements of an integrated drug delivery system and the critical interfaces between them. These four elements are:
West is uniquely positioned to understand and support this need, combining leadership in drug containment systems with device development and manufacturing expertise, and a network of industry partnerships aimed at ensuring optimum packaging and delivery systems for today’s sophisticated drug products. Examples of solutions will be briefly discussed, including Daikyo Crystal Zenith® containment systems and the SmartDose® electronic patch injector, which is an ideal example of an integrated packaging and delivery system that meets a growing market need.
Graham Reynolds
VP & GM, Global Biologics
610 594 2935
Graham.Reynolds@westpharma.com
West markets SmartDose® as a multi-component system only. Final assembly of the prefilled component is completed by the pharmaceutical company. SmartDose® is a registered trademark of Medimop Medical Projects Ltd., a subsidiary of West Pharmaceutical Services, Inc.
Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd. Daikyo Crystal Zenith technology is licensed from Daikyo Seiko, Ltd.